Boehringer Ingelheim has expanded its oncology focus for the second time this week by buying Swiss biotech NBE-Therapeutics, adding an antibody-drug conjugate (ADC) platform led by a drug for a ...
BASEL, Switzerland, January 10, 2020 / B3C newswire / --NBE-Therapeutics AG today announces the closing of a USD 22M Series C financing round, led by its existing shareholders Boehringer Ingelheim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results